BATS BZX Real-Time Price
As of 3:50pm ET
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +86.67% increase from the last price of 7.50.
The current consensus among 6 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.